Last quarter (Q ), Atrys Health SA's total revenue was €―, a decrease of ― from the same quarter last year. In Q, Atrys Health SA's net income was €―. See Atrys Health SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	€ 186.99M	€ 121.01M	€ 31.40M	€ 14.84M	€ 7.29M
Cost of Revenue	-	€ 32.48M	€ 20.12M	€ 7.15M	€ 2.64M	€ 421.78K
Gross Profit	-	€ 154.51M	€ 100.89M	€ 24.25M	€ 12.20M	€ 6.87M
Operating Expense	-	€ 154.83M	€ 113.28M	€ 22.46M	€ 11.01M	€ 6.17M
Operating Income	-	€ -318.00K	€ -12.39M	€ 1.79M	€ 1.19M	€ 706.05K
Net Non Operating Interest Income Expense	-	€ -14.38M	€ -9.19M	€ -2.14M	€ -1.07M	€ -621.49K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	€ -24.69M	€ -24.88M	€ -1.31M	€ 206.65K	€ 63.64K
Tax Provision	-	€ -1.23M	€ -1.69M	€ 706.61K	€ 311.43K	€ 51.65K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	€ -23.26M	€ -23.25M	€ -2.02M	€ -104.78K	€ 11.99K
Basic EPS	-	€ -0.34	€ -0.46	€ -0.07	€ >-0.01	-
Diluted EPS	-	€ -0.34	€ -0.46	€ -0.07	€ >-0.01	-
Basic Average Shares	-	€ 68.20M	€ 50.28M	€ 28.32M	€ 21.46M	-
Diluted Average Shares	-	€ 71.47M	€ 53.52M	€ 30.99M	€ 22.86M	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	€ 862.00K	€ 997.00K	-	-	-
Total Expenses	-	€ 187.31M	€ 133.41M	€ 29.60M	€ 13.65M	€ 6.59M
Net Income From Continuing And Discontinued Operation	-	€ -23.26M	€ -23.25M	€ -2.02M	€ -104.78K	€ 11.99K
Normalized Income	-	€ -14.95M	€ -21.80M	€ -1.99M	€ -182.44K	€ 74.31K
Interest Expense	-	€ 4.01M	€ 11.03M	€ 2.26M	€ 1.06M	€ 609.44K
EBIT	-	€ -20.69M	€ -13.85M	€ 951.52K	€ 1.27M	€ 673.08K
EBITDA	-	€ 9.66M	€ 6.94M	€ 4.78M	€ 3.17M	€ 1.95M

Currency in EUR

Atrys Health SA Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing